Family studies of B lymphocyte alloantigens in systemic lupus erythematosus. 1982

J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann

In Caucasians with systemic lupus erythematosus (SLE), we have identified 3 risk markers in the HLA-D region -- HLA-DR2, HLA-DR3, and la-715 -- and have used these markers to probe 7 families in which more than 1 case of lupus had occurred. In 6 of the 7 families studied, persons with SLE were either homozygous for HLA-DR2, had 2 haplotypes carrying reactivity with la-715, or had at least 2 of the 3 risk markers HLA-DR2, HLA-DR3, and la-715. Several normal individuals in these kindreds also had these multiple risk markers but had no signs or symptoms of lupus. This limited study of lupus families suggests a role for coinheritance of HLA-D region genes as a factor in the development of SLE.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005260 Female Females
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
September 1978, The New England journal of medicine,
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
January 2012, Revista medica del Instituto Mexicano del Seguro Social,
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
January 1964, Acta medica Scandinavica,
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
December 1967, Clinical and experimental immunology,
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
April 1972, Journal of chronic diseases,
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
April 2002, Rheumatology (Oxford, England),
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
January 1972, Acta medica Scandinavica. Supplementum,
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
July 2019, Clinical immunology (Orlando, Fla.),
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
October 1981, Journal of clinical immunology,
J L Reinersten, and J H Klippel, and A H Johnson, and A D Steinberg, and J L Decker, and D L Mann
November 2000, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!